A line shape characterized by a bell-shaped form; proportional to exp (-(f - f0)2/Df2) where Df is a measure of the line width.

Noise distributed in a normal (Gaussian) pattern. In such a distribution, approximately 65% of all points fall within one standard deviation (s) of the mean.

Macromolecular Gd labeled albumins are a new class of contrast agents with a wide range of use e.g., MR angiography, breast MRI, perfusion MRI, Lung perfusion, etc.
Marketed gadolinium-based albumin-bound contrast media are e.g., MultiHance®, and Vasovist™; other prototypes are in development. Malignant tumors often show an increased uptake and metabolism of plasma proteins, especially albumin. Contrast agents with large molecules are delivered to all tissues, but only accumulate in those with leaky vessels by tumor capillaries (tumor neovessels). MRI tumor perfusion studies with Gd labeled albumin can show the success of tumor therapy by quantitative decrease in MR signal of the malignant tissue after therapy compared to before. In addition, the study of tumor sensitivity to a therapy with drug-labeled albumins seems possible.
After renal transplantation, MRI may diagnose albuminuria caused by glomerular disease with an albumin-bound blood pool contrast agent

See also Blood Pool Agents, Intravascular Contrast Agents, Contrast Enhanced MRI.

Short name: Gd-2,5-BPA-DO3A, central moiety: Gd
A paramagnetic agent that undergo hepatic uptake and biliary excretion, therefore Gd-2,5-BPA-DO3A can act as a hepatospecific MRI contrast agent.

Short name:(Gd-DTPA)n-dextran, central moiety: Gd2+
Gd-DTPA labeled dextran is a substance that has been tested as a blood pool agent (intravascular MRI contrast agent). Dextran is a polysaccharide and has labeled with 15 Gd-DTPA moieties a higher T1 relaxivity than unbound Gd-DTPA, compared with a high safety level.

See also Intravascular Contrast Agents, Blood Pool Agents.